← Back to Search

Experimental Group 2 for Chronic Lower Back Pain (VIGOR Trial)

N/A

Waitlist Available

Led By James S Thomas, P.T., Ph.D.

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline 1-, 6-, 12-, 24-, and 48-weeks post-treatment

Awards & highlights

VIGOR Trial Summary

This trial will explore whether playing video games can help people with chronic low back pain by improving their movement.

Eligible Conditions

Chronic Lower Back Pain
Atychiphobia
Injury Phobia

VIGOR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline 1-, 6-, 12-, 24-, and 48-weeks post-treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline 1-, 6-, 12-, 24-, and 48-weeks post-treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline 1-, 6-, 12-, 24-, and 48-weeks post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Disability

Change in Pain

Secondary outcome measures

Change in Lumbar Spine Flexion

Change in Pain & Harm Expectancy

Change in Real World Activity

Other outcome measures

Change in Emotional Functioning

Change in Pain Interference with Physical Function

Change in Pain Resilience

+3 more

VIGOR Trial Design

2Treatment groups

Experimental Treatment

Group I: Experimental Group 2Experimental Treatment1 Intervention

Participants will produce progressively larger lumbar flexion excursions at each game level and across treatment sessions.

Group II: Experimental Group 1Experimental Treatment1 Intervention

Participants will produce progressively larger lumbar flexion excursions at each game level and across treatment sessions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Experimental Group 1

2019

N/A

~160

Experimental Group 2

2019

N/A

~160

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,963 Previous Clinical Trials

2,674,582 Total Patients Enrolled

Virginia Commonwealth UniversityLead Sponsor

697 Previous Clinical Trials

22,884,837 Total Patients Enrolled

Ohio UniversityOTHER

69 Previous Clinical Trials

37,055 Total Patients Enrolled

Media Library

Experimental Group 1 Clinical Trial Eligibility Overview. Trial Name: NCT03463824 — N/A

Chronic Lower Back Pain Research Study Groups: Experimental Group 1, Experimental Group 2

Chronic Lower Back Pain Clinical Trial 2023: Experimental Group 1 Highlights & Side Effects. Trial Name: NCT03463824 — N/A

Experimental Group 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT03463824 — N/A

Chronic Lower Back Pain Patient Testimony for trial: Trial Name: NCT03463824 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who would be an appropriate candidate for participation in this medical experiment?

"This clinical trial seeks 230 individuals aged 18-60 who are experiencing fear of injury. In addition, they must have an average pain intensity greater than 3 on a 0-10 scale, disability rating above 4 according to the Roland and Morris Disability Questionnaire, agreement with the statement "It is not really safe for me to be physically active," Tampa Scale of Kinesiophobia score in excess of 36, have sought consultation from a health care provider concerning back pain, and meet category 1-3 on the Quebec Task Force on Spinal Disorders Classification System which reflects low back pain without neurological signs that has been ongoing for at least half the days"

Answered by AI

Is the research team currently looking for participants?

"Current information on clinicaltrials.gov states that this medical trial is open to enrollment, with the initial posting occurring on January 10th 2019 and a recent update made September 7th 2022."

Answered by AI

Does this trial allow participants of 18 years or older to enroll?

"Those wishing to partake in this medical trial must meet the age criteria of 18-60. There are 11 trials available for minors and 264 studies designed specifically for those aged 65 or above."

Answered by AI

Approximately how many participants are involved in this research undertaking?

"Indeed, according to clinicaltrials.gov this research is presently enrolling patients. This trial was initially shared on January 10th 2019 and most recently amended on September 7th 2022. A total of 230 people are needed at a single location for the experiment to be conducted."

Answered by AI